KCNV2 and juvenile myoclonic epilepsy: In addition to R7K and M285R, the KCNV2 rs7029012 variant has also been associated with the risk of juvenile myoclonic epilepsy, as it can affect the binding of the acting element by inducing changes in KCNV2 expression [9,16].